Tesi is a Finnish venture capital and private equity firm that invests in promising Finnish companies to help them grow. They operate as a minority investor, partnering with private investors and making market-driven investments. Their primary goal is to build growth and develop the Finnish capital investment market, showcasing a commitment to societal impact alongside financial returns. Tesi's investment strategy emphasizes collaboration with other investors to provide growth funding and expertise to Finnish companies, fostering their expansion and internationalization. The firm has a broad approach, investing across various sectors and company stages, but with an emphasis on scaleups. They aim to act as a catalyst for growth, supporting companies with both capital and strategic guidance. Tesi's role is unique in the Finnish economic and societal landscape, as highlighted in the documentary "Sijoitus Suomeen". They actively contribute to the development of the Finnish economy through their investments and market development activities. A key aspect of their new investment strategy includes working alongside private investors in a market-driven manner, with a focus on minority positions. Tesi's investment approach is guided by the principles of market-driven decision-making and collaboration with private investors. The firm is dedicated to fostering the growth and internationalization of Finnish companies, thereby strengthening the Finnish economy and contributing to broader societal benefits. They aim to drive long-term value creation by actively supporting their portfolio companies and developing the Finnish capital investment market as a whole. They also emphasize their role in building growth and developing the capital investment market over the past 30 years. Based on the provided data, Tesi seems to have a particular focus on supporting companies that contribute to a more sustainable future, as indicated by investments in areas like small modular reactors for district heating (Steady Energy), alternative protein sources (Onego Bio), and companies enhancing digital resilience in Europe (UpCloud). They also invest in companies employing AI for medical advancements (Avenue Biosciences).
Preferred startup development maturity for initial funding deployment.
Energy technology, digital resilience, alternative proteins, biotech, scale-ups
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...